Day 1 - Wednesday, 27 June 2018
Meeting category
Date(s)
27 Jun 2018 - 28 Jun 2018
Location
Hong Kong,
China
Organizer
Asia-Pacific HIV Clinical Forum 2018
Related Enduring Materials
Enduring Materials
Session 1: New technologies and formulations -
Chairs
Patrick Li, MBBS, FHKCP, FHKAM, FRCP, FRCP
Hong Kong Sanatorium and Hospital, Hong Kong SAR, China
Jonathan Schapiro, MD
Sheba Medical Center, Israel
Transmitted Integrase Inhibitor Resistance - State of the Art
Acquired Integrase Inhibitor Resistance - State of the Art
Clinical Pharmacology of Integrase Inhibitors - State of the Art
Session 2: Clinical Utility of Integrase Inhibitors -
Chairs
Daniel Kuritzkes , MD
Harvard Medical School, USA
Fujie Zhang, MD, PhD
Beijing Ditan Hospital, Capital Medical University, China
Impact of Integrase Inhibitors on the HIV epidemic in Asia
Matthew Law, BA(Hons), MSc, PhD
University of New South Wales, The Kirby Institute, Australia
Optimal use of Integrase Inhibitors in routine clinical practice
Integrase Inhibitors in second line treatment
Clinical Case - Emphasis on Integrase Inhibitors challenges in Asian countries
Session 3: Special Considerations Address Challenging Populations -
Chairs
Kees Brinkman, MD, PhD
Onze Lieve Vrouwe Gasthuis, the Netherlands
Saye Khoo, MD, PhD
University of Liverpool, United Kingdom
Role of Integrase Inhibitors in the clinical care of HIV infected pregnant women and adolescents
Clinical Case - InSTIs use in Hong Kong
Novel Delivery Systems
Day 2 - Thursday, 28 June 2018
Session 4: Next generation of Antiretroviral Treatment Strategies -
Chien-Ching Hung, MD, PhD
Chairs
Charles Boucher, MD
Erasmus Medical Center, the Netherlands
Mark Boyd, BA, BM, BS, MHID, DCTM&H, MD, FRACP
University of Adelaide, Australia
The role of InSTIs in International Treatment Guidelines
Reduced Drug Regimens
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan
Overview
Welcome
We would like to thank you for joining us at the second edition of the Asia-Pacific HIV Clinical Forum in Hong Kong, preceding the APACC 2018.
The meeting was an incredible success with more than 160 attendees visiting the meeting! Also with excellent discussions and lectures during this meeting.
On behalf of the Program Chairs we would like to thank our conference supporters ViiV Healthcare & Gilead or their unrestricted generous support to our endorser Youth Against AIDS for supporting this meeting!
Background
The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.
Support
Support
